Carbidopa

Overview

Carbidopa is a medication used in the management of Parkinson's disease, often in combination with levodopa. It acts by inhibiting the enzyme aromatic L-amino acid decarboxylase, thereby preventing the conversion of levodopa into dopamine outside the brain.

API suppliers (18)

Suppliers of Carbidopa backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• TAPI NL BV2 active DMF
• INVENTAA INDUSTRIES PRIVATE LTD1 active DMF
• BACHEM INC1 active DMF
• INVENTAA INDUSTRIES PRIVATE LTD1 active DMF
• BACHEM INC1 active DMF
• FERMION OYFinland1 active DMF
• Zhejiang Medicine Co., Ltd.China1 active DMF
• INVENTAA INDUSTRIES PRIVATE LTD1 active DMF
• DPT Laboratories, Ltd.United States1 active DMF
• Zhejiang Medicine Co., Ltd.China1 active DMF
• Nippon Kayaku Co., Ltd.Japan
• AMERICAN CHEMICAL INDUSTRIAL CORP
• DAITO CORP
• EGIS PHARMACEUTICALS PRIVATE LTD
• ESTEVE QUIMICA SA
• JUZEN CHEMICAL CORPJapan
• KNOLL AG
• SMRUTHI ORGANICS LTD

Therapeutic areas